AMP 2011 Annual Meeting
Gaylord Texan Hotel & Convention Center
Grapevine, Texas
November 17-19, 2011

CME Application Deadline - March 1, 2012
Mobile App now available! View more information and download the app now.
Tuesday, November 15, 2011 |
|
| 8:00am - 5:00pm | GeT-RM Panel Meeting 2011 |
| 11:30am - 6:00pm | AMP Council Meeting (Invitation Only) |
| 4:00pm - 9:00pm | Attendee and Registration, Check-in |
| 6:30pm | Council Dinner (Invitation Only) |
Wednesday, November 16, 2011 |
|
| 7:00am - 6:00pm | Attendee and Exhibitor Registration, Check-in for Annual Meeting |
| 7:30am - 8:30am | Registration, Continental Breakfast for Outreach Course |
| 8:30am - 3:30pm | MOLECULAR PATHOLOGY OUTREACH COURSE (Separate Registration and CME Activity) |
| 9:00am - 6:00pm | CORPORATE WORKSHOPS - (See Separate Schedule) [NOT CME] |
| 7:00am - 7:00pm | AMP Committee. Interest Group & Working Group Meetings [NOT CME] |
| 5:30pm - 7:00pm | CAP Workshop: Accreditation Requirements in Molecular Pathology Workshop [Separate Registration and CME from CAP] |
| 6:00pm - 7:00pm | MGP Program Directors Meeting [NOT CME] |
| 6:00pm - 7:00pm | International Affairs Working Group [NOT CME] |
| 7:30 pm - 9:30pm | Abbott Reception [NOT CME] |
Thursday, November 17, 2011 |
|||
| 7:00am - 6:00pm | Attendee and Exhibitor Registration, Check-in | ||
| 7:00am - 8:00am | Continental Breakfast | ||
| 1:00pm - 5:00pm | Exhibits Open | ||
| SCIENTIFIC PROGRAM | |||
| 7:00am - 7:45am | EARLY BIRD SESSIONS | ||
| Million Veteran Program Moderator: Federico A. Monzon, MD, Baylor College of Medicine, Houston, TX |
|||
| VA Office of Research & Devlopment Million Veterans Program Ronald M. Przgodzki, MD, US Department of Veteran Affairs,Washington, DC |
|||
| LAMP Discussion [NOT CME] Moderator: Randall T. Hayden, MD, St. Jude Children's Research Hospital, Memphis, TN |
|||
| Principles of LAMP Technology and It's Applications For Molecular Diagnostics Slava A. Elagin, PhD, MBA, Meridian Bioscience, Inc., Cincinnati, OH |
|||
| New Info: NIH Genetic Testing Registry Moderator: Alexis B. Carter, MD, Emory University Hospital, Atlanta, GA |
|||
| Wendy Rubinstein, MD, PhD, NIH Genetic Testing Registry, Bethesda, MD | |||
| 7:45am - 8:00am | Break | ||
| 8:00am - 8:15am | Opening Remarks Jennifer L. Hunt, MD, MEd, University of Arkansas for Medical Science, Little Rock, AR |
||
| 8:15am - 9:30am | AMP AWARD FOR EXCELLENCE IN MOLECULAR DIAGNOSTICS LECTURE Supported by an Unrestricted Educational Grant from Roche Diagnostics |
||
| Presentation of the Award and Moderator: Timothy J. O'Leary, MD, PhD, Veterans Administration, Washington, DC | |||
| Causes and Consequences of microRNA Dysregulation in Cancer Carlo M. Croce, MD, Ohio State University, Columbus, OH |
|||
| 9:30am -9:45am | Coffee Break Supported by Novartis |
||
| 9:45am - 11:15am | PLENARY SESSION: JUST IN TIME (Late-breaking Topics) Supported by an unrestricted educational grant from Abbott Molecular Moderator: Jennifer Hunt, MD, MEd, University of Arkansas for Medical Science, Little Rock, AR |
||
| Cell Lines, Chemotherapy Response, and the Need for Reproducible Research Kevin R. Coombes, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX |
|||
| E. Coli Strikes Europe With a Vengeance! The Role of Genomics in Outbreak Settings David A. Rasko, PhD, University of Maryland School of Medicine, College Park, MD |
|||
| 11:15am -11:30am | Coffee Break | ||
| 11:30am -12:30pm | CONCURRENT WORKSHOPS | ||
| microRNA Applications in Oncology Moderators: George J. Netto, MD, John Hopkins Medical Institutions, Baltimore, MD and Federico A. Monzon, MD, Baylor College of Medicine, Houston, TX |
|||
| Next Generation Sequencing and Pathology Practice: A Source of New Tools or the Tool Itself David Huntsman, MD, British Columbia Cancer Agency & University of British Columbia, Vancouver, BC, Canada |
|||
| Viewpoints on Payment for Complex and Innovative Molecular Testing Moderator: D. Brian Dawson, PhD, Mayo Clinic, Rochester, MN |
|||
| Payment for Complex and Innovative Molecular Testing: Payer and Provider Viewpoints Kathleen S. Wilson, MD, University of Texas Southwestern Medical School, Dallas, TX |
|||
| The Payer View on Payment for Complex and Innovative Molecular Testing Lee N. Newcomer, MD, UnitedHealthcare Services, Minnetonka, MN |
|||
| Platform Presentations of Selected Genetics Abstracts Ira Lubin, PhD, Centers for Disease Control and Prevention, Atlanta, GA |
|||
| [11:34am] G42-A Multi-Gene Assay Coupled with Bioinformatics: An Interdisciplinary Approach to Pharmacogenetics Testing Gladys Garrison, MS, BSMT (ASCP), Vanderbilt University Medical Center, Nashville, TN |
|||
| [11:47am] G51-Importance of Complete Genomic Analysis Using Conventional G-banded Chromosome Analysis and SNP Microarray Analysis in Cases with Known Chromosome Abnormalities Teresa A. Smolarek, PhD, Cincinnati Children's Hospital Medical Center, Cincinnati, OH |
|||
| [12:00pm] G60-A Comprehensive Review of Genetics Sendout Testing Barathi Vennapusa, MD, University of Pittsburg Medical Center, Pittsburg, PA Presented By: Jeffrey Kant |
|||
| [12:13pm] G64-Next Generation Sequencing in Clinical Diagnostic Laboratories: Implementation of Quantitative and Qualitative controls in Dual Genome Analysis Wei Zhang, MD, PhD, Medical Genetics Laboratories, Baylor College of Medicine, Houston, TX |
|||
| Platform Presentations of Selected Hematopathology Abstracts Supported by an unrestricted educational grant from Abbott Molecular Moderators: Charles E. Hill, MD, PhD, Emory University Hospital, Atlanta, GA and James R. Cook, MD, PhD, Cleveland Clinic Foundation, Cleveland, OH |
|||
| [11:34am] H02- Analysis of Clonal T-cell Receptor Gene Rearrangements Utilizing Next Generation Sequencing Timothy C. Greiner, MD, University of Nebraska Medical Center, Omaha, NE [11:47am] H04-Targeted Next Generation Sequencing of Clinically Significant Gene Mutations and Translocations in Leukemia Eric Duncavage, MD, Washington University, St. Louis, MO [12:00pm] H18- DNMT3A Mutations in Acute Myeloid Leukemia and Myelodysplastic Syndrome Talia N. Mitchell, BS, MB (ASCP), Memorial Sloan-Kettering Cancer Center, New York, NY [12:13pm] H20- Array Cytogenomics as a Diagnostic Aid for Acute Myeloid Leukemia: A Comparison of Four Different Platforms Jeremy P. Segal, MD, University of Pennsylvania, Philadelphia, PA |
|||
| 12:30pm - 1:30pm | Concurrent Lunches (Open to all registered attendees) |
||
| Joint Subdivision Lunch Forum | |||
| General Lunch | |||
| 1:30pm - 2:45pm | Break, Visit Posters & Exhibits: Even-numbered and Award Posters attended [NOT CME] | ||
| 2:45pm - 3:45pm | CONCURRENT WORKSHOPS | ||
| Applying Statistics to Multianalyte and Multitarget Testing Moderator: Joan H. Gordon, MT(ASCP), Maine Molecular Quality Controls, Inc., Scarborough, ME |
|||
| Removing Perplexity from the Verification of Multiplex Molecular Methods: Statistical Practices for Assessing Performance of Multi-target Assays Donna M. Wolk, PhD, D(ABMM), University of Arizona, Tucson, AZ |
|||
| Evolution of QC Practices and Development of Multiplex QC Procedures James O. Westgard, PhD, FACB, Westgard QC, Inc, Madison, WI |
|||
| Genetics of Primary Immunodeficiency Syndromes: Newborn Screening and Follow-up Assays Moderators: D. Brian Dawson, PhD, Mayo Clinic, Rochester, MN and Ira Lubin, PhD, Centers for Disease Control and Prevention, Atlanta, GA |
|||
| Integrating Diagnostic Immunology and Molecular Testing in the Evaluation of Primary Immunodeficiencies Attila Kumanovics, MD, The University of Utah, Salt Lake City, UT |
|||
| Clinical Application of Whole Genome Sequencing David Dimmock, MD, Medical College of Wisconsin, Milwaukee, WI |
|||
| Platform Presentations of Selected Infectious Diseases Abstracts Moderators: Randall T. Hayden, MD, St. Jude Children's Research Hospital, Memphis, TN and Lance R. Peterson, MD, Evanston Northwestern Healthcare, Evanston, IL |
|||
| [2:49pm] ID11-Allele Frequency of An IL28B Treatment-predictive SNP in HCV-Infected Patients Daphne C. Ang, MD, OHSU, Portland, OR [3:02pm] ID45-Mupirocin Resistance in Methicillin-resistant Staphylococcus Aureus (MRSA) Colonized Residents in Long-Term Care Facilities (LTCFs) Carolyn M. Hines, Glenview Terrace, Glenview, IL Presented By: Sue Boehm [3:15pm] ID50- Improved Performance of Cervical Cancer Screening Using HPV E6, E7 mRNA Quantification with Polygonal Gating and Cellular Normalization Mary C. Schwab, BS, Dartmouth Medical School, Dartmouth-Hitchcock Medical Center, Lebanon, NH [3:28pm] ID65-Software Guided Assay Validation: Use of EZValidation TM in the Determination of the Performance Characteristics of a Real-Time PCR Assay Using MultiCode®-RTx for BKV Quantification Amy Greer, PhD, The Johns Hopkins Hospital, Baltimore, MD |
|||
| Platform Presentations of Selected Solid Tumors Abstracts Moderators: George J. Netto, MD, John Hopkins Medical Institutions, Baltimore, MD and Federico A. Monzon, MD, The Methodist Hospital System, Houston, TX |
|||
| [2:49pm] ST11 - Deep Sequencing of Target Genes in Solid Tumors Reveals New Deletions and Insertions in Microsatellite Sequences Jack X. Yu, PhD, Ortho Clinical Diagnostics, Raritan, NJ Presented By: Yixin Wang [3:02pm] ST14 - Evaluation of the OpenArray Platform for a Non-Invasive Melanoma Detection Assay Sherman Chang, PhD, DermTech International, San Diego, CA [3:15pm] ST24 - Comprehensive Approach for Molecular Testing of Thyroid FNA Samples Marina N Nikiforova, MD, Universty of Pittsburgh Medical Center, Pittsburgh, PA [3:28pm] ST56 - Comprehensive Molecular Analysis of High Grade Invasive Urothelial Bladder Carcinomas by Whole Genome, Mate-Pair, and Whole Exome Sequencing Linda .M Sabatini, PhD, Roswell Park Cancer Institute, Buffalo, NY |
|||
| 3:45pm - 4:00pm | Coffee Break Supported by Luminex |
||
| 4:00pm - 5:30pm | PLENARY SESSION: CIRCULATING TUMOR CELLS AND NUCLEIC ACIDS Supported by an unrestricted educational grant from Abbott Molecular Moderators: Daniel H. Farkas, PhD HCLD, Sequenom Center for Molecular Medicine, Grand Rapids, MI and Federico A. Monzon, MD, The Methodist Hospital System, Houston, TX |
||
| Noninvasive Prenatal Diagnosis by Next Generation Sequencing: from Dream to Reality Yuk-Ming Dennis Lo, MD, The Chinese University of Hong Kong, Hong Kong, China |
|||
| Development of a Membrane Microfilter Device for Capture and Characterization of Circulating Tumor Cells (CTC) from Blood Richard J. Cote, MD, University of Miami Leonard M. Miller School of Medicine, Miami, FL |
|||
| 5:30pm - 6:30pm | Welcome Reception Supported by Roche | ||
| 7:00pm - 9:00pm | JMD Editorial Board Meeting | ||
| 7:00pm - 11:00pm | Canadian Member Dinner Meeting | ||
| 7:00pm - 9:00pm | Indian Member Meeting | ||
Friday, November 18, 2011 |
|||
| 7:00am - 6:00pm | Attendee and Exhibitor Registration, Check-in | ||
| 7:00am - 8:00am | Continental Breakfast Supported by the College of American Pathologists |
||
| 9:00am - 5:00pm | Exhibits Open | ||
| SCIENTIFIC PROGRAM | |||
| 7:00am - 7:45am | EARLY BIRD SESSIONS | ||
| Advancements in FMR1 Methylation PCR [NOT CME] Moderator: W. Edward Highsmith, Jr., PhD, Mayo Clinic, Rochester, MN |
|||
| Technical Advances in Fragile X: Progress towards Eliminating the Southern Blot Gary Latham, PhD, Asuragen, Inc., Austin, TX |
|||
| Making the Transition from Southern Blots to PCR-based Methylation Testing Jessica K. Booker, PhD, FACMG, University of North Carolina School of Medicine, Chapel Hill, NC |
|||
| Building a Business Plan for Molecular: Comparison of Admission Screening for MRSA and Diagnostic Testing for Clostridium difficile Infection (CDI) [NOT CME] Moderator: Randall T. Hayden, MD, St. Jude Children's Research Hospital, Memphis, TN |
|||
| Speaker: Lance R. Peterson, MD, Evanston Northwestern Healthcare, Evanston, IL | |||
| 7:45am - 8:00am | Break | ||
| 8:00am - 9:30am | PLENARY SESSSION: SNP ARRAYS IN HEMATOPATHOLOGY AND SOLID TUMORS Supported by and unrestricted educational grant from QIAGEN Moderators: Charles E. Hill, MD, PhD, Emory University Hospital, Atlanta, GA, James R. Cook, MD, PhD, Cleveland Clinic Foundation, Cleveland, OH, and Federico A. Monzon, MD, The Methodist Hospital System, Houston, TX |
||
| The Cancer Cytogenomic Microarray Consortium Quality Control (CCMC-QC) Project: A Multi-Center, Cross-Platform Clinical Validation of Cancer Cytogenomic Arrays Jill Hagenkord, MD, Creighton University Medical Center, Omaha, NE |
|||
| Detection of Structural Variants in Myeloid Tumors Using Arrays and Whole Genome Sequencing Matthew J. Walter, MD, Washington University School of Medicine, St. Louis, MO |
|||
| 9:30am - 10:15am | Coffee Break, Visit Posters & Exhibits [NOT CME] |
||
| 10:15am - 11:45am | CONCURRENT WORKSHOPS | ||
| IgH Mutation Analysis Supported by an unrestricted educational grant from Abbott Molecular Moderators: Charles E. Hill, MD, PhD, Emory University Hospital, Atlanta, GA and James R. Cook, MD, PhD, Cleveland Clinic Foundation, Cleveland, OH |
|||
| The Significance of IGH Mutational Status in Chronic Lymphocytic Leukemia Prognosis Dave W. Bahler, MD, PhD, ARUP Laboratories, Salt Lake City, UT |
|||
| IGH Hypermutation Testing in Chronic Lymphocytic Leukemia Iris Schrijver, MD, Stanford University Medical Center, Stanford, CA |
|||
| Lung and Colorectal Cancer Guidelines Moderator: George J. Netto, MD, John Hopkins Medical Institutions, Baltimore, MD |
|||
| Pathology and Laboratory Medicine Practice Guidelines -- An Invitation to the Larger Discussion Jan Nowak, PhD, MD, Evanston Hospital, NorthShore University HealthSystem, Evanston, IL |
|||
| AMP-CAP-IASLC Guideline for Molecular Testing in Non-small cell Lung Cancer Neal Lindeman, MD, Brigham & Women's Hospital, Boston, MA |
|||
| AMP-ASCP-CAP Guideline for Molecular Testing in Colorectal Cancer Federico A. Monzon, MD, The Methodist Hospital System, Houston, TX |
|||
| 2012 Molecular CPT Coding Structure for Oncology and Genetics Testing Reveals (almost) All! Moderator: Jeffrey Kant, MD, PhD, University of Pittsburgh Medical Center, Pittsburgh, PA |
|||
| Speakers: Jeffrey Kant, MD, PhD, University of Pittsburgh Medical Center, Pittsburgh, PA Roger Klein, MD, JD, Blood Center of Wisconsin, Milwaukee, WI Victoria Pratt, PhD, Quest Diagnostics Nichols Institute, Chantilly, VA |
|||
| Anti-Viral Susceptibility Testing Moderators: Randall T. Hayden, MD, St. Jude Children's Research Hospital, Memphis, TN and Lance R. Peterson, MD, Evanston Northwestern Healthcare, Evanston, IL |
|||
| The Role of Resistance Testing in the Management of Herpesvirus Infections Hank Balfour, MD, University of Minnesota, Minneapolis, MN |
|||
| Molecular Detection of Influenza A Variants and Antiviral Resistance Karen Kaul, MD, PhD, NorthShore University HealthSystem, Evanston, IL |
|||
| 11:45am - 12:45pm | Concurrent Lunches (Open to all registered atendees) | ||
| AMP's Future (Update from Council) | |||
| General Lunch | |||
| 12:45pm - 2:15pm | PLENARY SESSSION: NEXT GENERATION SEQUENCING Supported by an unrestricted educational grant from Abbott Molecular Moderators: Ira Lubin, PhD, Centers for Disease Control and Prevention, Atlanta, GA and George J. Netto, MD, John Hopkins Medical Institutions, Baltimore, MD |
||
| Pancreas Pathology in the Era of Whole Genome Sequencing Ralph Hruban, MD, Johns Hopkins Medical Institutions, Baltimore, MD |
|||
| Next Generation Clinical Sequencing in a Children's Hospital Stephen F. Kingsmore, MB ChB DSc FRCPath, Children's Mercy Hosptials and Clinics, Kansas City, MO |
|||
| 2:15pm - 3:30pm | Coffee Break, Visit Posters & Exhibits: Odd-numbered Posters Attended [NOT CME] Supported by Luminex |
||
| 3:30pm - 5:00pm | CONCURRENT SYMPOSIA | ||
| Next Gen Sequencing: Development and Implementation Moderator: Karl Voelkerding, MD, ARUP Laboratories, Salt Lake City, UT |
|||
| Clinical Next Generation Sequencing for Inherited Cardiomyopathies Birgit Funke, PhD, Partners HealthCare Center for Personalized Genetic Medicine, Cambridge, MA |
|||
| Clinical Interpretation of Targeted Panels and Exome Sequencing: Phenotype Driven Analysis and Complimentary Assays Madhuri Hegde, PhD, Emory University School of Medicine, Atlanta, GA |
|||
| Exome and Whole Genome Sequencing in a Clinical Research Settings Karl Voelkerding, MD, ARUP Laboratories, Salt Lake City, UT |
|||
| Molecular Testing in the Developing World Moderator: Helen D. Fernandes, PhD, UMDNJ-New Jersey Medical School, Newark, NJ |
|||
| Barriers and Opportunities to Introduction of Molecular Diagnostics to Resource-Limited Setting Gonzalo Domingo, PhD, PATH, Seattle, WA |
|||
| Molecular Diagnostics for Infectious Diseases in Resource-Limited Settings Hui Wang, PhD, Peking University People's Hospital, Beijing, China |
|||
| 5:00pm - 5:15pm | Break | ||
| 5:15pm - 6:30pm | BusinessMeeting and Awards Session [NOT CME] | ||
| ICPI Trainee Travel Award (Sponsored by the Intersociety Council for Pathology Information) | |||
| American Society for Investigative Pathology (ASIP) Minority Trainee Travel Award (Funded by a grant from the National Institute of General Medical Sciences, National Institutes of Health [FASEB MARC Program: T36-GM08059-28]) | |||
| AMP Technologist Travel Awards | |||
| AMP Technologist Awards (Supported by Hologic) | |||
| AMP Young Investigator Awards (Supported by Luminex Corporation) | |||
| AMP Leadership Award (Supported by Abbott Molecular) | |||
| 6:30pm - 7:30pm | Awards Reception Supported by Hologic | ||
| 7:30pm - 10:30pm | Social Event (Ticket required) | ||
Saturday, November 19, 2011 |
|||
| 7:00am - 5:00pm | Atendee and Exhibitor Registration, Check-in | ||
| 7:00am - 8:00am | Continental Breakfast Supported by Slone Partners |
||
| 9:00am - 4:00pm | Exhibits Open | ||
| 7:00am - 7:45am | EARLY BIRD SESSIONS | ||
| Difficult Cases in Solid Tumors Moderator: George J. Netto, MD, John Hopkins Medical Institutions, Baltimore, MD |
|||
| Speaker: Marina N. Nikiforova, MD, FCAP, University of Pittsburgh, Pittsburgh, PA | |||
| Establishing Reference Sequences and Resources to Assist Gene/Allele Nomenclature and with Interpretation of Sequence Variants Moderator: Margaret L. Gulley, MD, University of North Carolina School of Medicine, Chapel Hill, NC |
|||
| Speaker: Donna Maglott, PhD, National Library of Medicine, NIH, Bethesda, MD |
|||
| 7:45am - 8:00am | Break | ||
| 8:00am - 9:30am | CONCURRENT WORKSHOPS |
||
| Alterations in AML and MDS Moderators: Charles E. Hill, MD, PhD, Emory University Hospital, Atlanta, GA and James R. Cook, MD, PhD, Cleveland Clinic Foundation, Cleveland, OH |
|||
| WHO Approach to Diagnosis of Acute Myeloid Leukemia: Current Role of Molecular Genetic Markers Daniel A. Arber, MD, Stanford University Medical Center, Stanford, CA |
|||
| Emerging Molecular Markers in Acute Myeloid Leukemia: The How and Why of What Comes After WHO Adam Bagg, MD, University of Pennsylvania |
|||
| Arrays and More: Genome-wide Diagnostic Approaches in Children with Developmental Delay or Autism Spectrum Disorders Moderator: D. Brian Dawson, PhD, Mayo Clinic, Rochester, MN |
|||
| Chromosomal Microarrays: The Benefits and Limitations of Genome-Wide Analysis Erik C. Thorland, PhD, Mayo Clinic, Rochester, MN |
|||
| Clinical Applications of Multi-locus Genetic Testing G. Bradley Schaefer, MD, University of Arkansas for Medical Sciences, Little Rock, AR |
|||
| Preparing for Genome Era Pathology Moderator: Jennifer L. Hunt, MD, MEd, University of Arkansas for Medical Science, Little Rock, AR |
|||
| Training Residents in Genomics: Creating a Genomics Curriculum for Pathology Residency Training Programs Karen Kaul, MD, PhD, NorthShore University HealthSystem, Evanston, IL |
|||
| Preparing Pathologists for the Practice of Genomics Debra G. B. Leonard, MD, PhD, Weill Cornell Medical College, New York, NY |
|||
| The Human Microbiome Moderators: Randall T. Hayden, MD, St. Jude Children's Research Hospital, Memphis, TN and Lance R. Peterson, MD, Evanston Northwestern Healthcare, Evanston, IL |
|||
| The Human Virome; Progress to Date and Implications for Clinical Medicine Gregory Storch, MD, Washington University School of Medicine, St. Louis, MO |
|||
| Metagenomics and Implications for Molecular Pathology James Versalovic, MD, PhD, Texas Children's Hospital, Houston, TX |
|||
| 9:30am - 10:15am | Coffee Break, Visit Posters & Exhibits [NOT CME] Supported by Novartis |
||
| 10:15pm - 11:45pm | PLENARY SESSION: MULTIANALYTE TESTING IN INFECTIOUS DISEASES Moderators: Randall T. Hayden, MD, St. Jude Children's Research Hospital, Memphis, TN and Lance R. Peterson, MD, Evanston Northwestern Healthcare, Evanston, IL |
||
| A Review of Multianalyte Platforms for Detection of Respiratory Tract Viral Infections Christine Ginocchio, PhD, North Shore-LIJ Health System Laboratories, Lake Success, NY |
|||
| Multi-Analyte Testing of Infectious Agents; Integration into Clinical Practice Karen M. Frank, MD, PhD, University of Chicago Medical Center, Chicago, IL |
|||
| 11:45am - 12:45pm | Lunch [NOT CME] | ||
| General Lunch and Table Topics (Open to all registered attendees) Note: More information on Table Talks can be found on the "Information Board" by the Registration Desk. |
|||
| Trainee Lunch: Pathways to Molecular Training and Practice (Open to all registered trainees) Alexander Craig Mackinnon, MD, PhD, Medical College of Wisconsin, Milwaukee, WI Followed by a panel discussion |
|||
| International Affairs Working Group Table Talk Lunch for attendees from outside of North America |
|||
| Mutation Nomenclature Working Group Table Talk Lunch | |||
| 12:45pm - 2:15pm | CONCURRENT SYMPOSIA | ||
| Informatics: Analyzing and Reporting Next Generation Sequencing Data Moderator: Karl Voelkerding, MD, ARUP Laboratories, Salt Lake City, UT |
|||
| Next Generation Sequencing Bioinformatics: From Data Analysis to Reporting David Crockett, PhD, ARUP Laboratories, Salt Lake City, UT Jacob Durtschi, B.Sc, ARUP Laboratories, Salt Lake City, UT Perry G. Ridge, M.Sc, ARUP Laboratories, Salt Lake City, UT |
|||
| Regulatory Update: LDTs and Companion Diagnostics [NOT CME] Moderator: Andrea Ferreira-Gonzalez, PhD, Virginia Commonwealth University/MCV, Richmond, VA |
|||
| Companion Diagnostics: Manufacturer Perspective Stephen Little, PhD, Qiagen Ltd, Manchester, United Kingdom |
|||
| The Latest from FDA on LDTs, RUOs, and Companion Diagnostics Alberto Gutierrez, PhD, OIVD/CDRH/FDA, Silver Spring, MD |
|||
| 2:15pm - 2:45pm | Coffee Break, Visit the Exhibits Supported by Luminex |
||
| 2:45pm - 4:15pm | PLENARY SESSION: PHARMACOGENOMICS: MOLECULAR GENETICS IN DRUG DEVELOPMENT Moderator: Barbara A. Zehnbauer, PhD, Centers for Disease Control and Prevention, Atlanta, GA |
||
| The Use of Molecular Diagnostics to Guide Drug Development and Patient Tailoring Andrew E. Schade, MD, PhD, Eli Lilly Department of Diagnostics Research and Development, Indianapolis, IN |
|||
| Molecular Profiling of Solid Tumors for Targeted Therapy Cindy L. Vnencak-Jones, PhD, Vanderbilt University School of Medicine, Nashville, TN |
|||
| 4:15pm - 4:30pm | Closing Remarks Jennifer L. Hunt, MD, MEd, University of Arkansas for Medical Science, Little Rock, AR |
||
|
|||